Intervenant

Olivier BRANDICOURT

Chief Executive Officer - SANOFI

Olivier Brandicourt joined Sanofi in April 2015 as Chief Executive Officer.
Prior to joining the Group, Brandicourt was Chief Executive Officer of Bayer Healthcare AG (2013-2015). From 2000 through to 2013, he held a series of leadership positions at Pfizer culminating as a member of the Executive Leadership Team and as President and General Manager of the Emerging Markets and Established Products business units.
Brandicourt started his career in the pharmaceutical industry in 1987 as a Medical Director for the Region Africa at Warner-Lambert/Parke-Davis, where he held other senior positions in medical and marketing before being appointed General Manager of Canada. He also spent eight years with the Institute of Infectious and Tropical Diseases at the Pitié-Salpêtrière Hospital in Paris with a focus on malaria research in West and Central Africa and two years in the Republic of Congo as a doctor.
Olivier Brandicourt studied medicine in Paris where he specialized in Infectious Diseases and Tropical Medicine (University of Paris V) and holds an Advanced Degree in Cellular and Immunological Pathophysiology from the Paris Descartes University. He also holds a Master’s Degree in Biology (University of Paris XII).